title: Hypertrophic osteoarthropathy with imatinib therapy.
authors.affiliation: Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
authors.forename: T
authors.initials: T
authors.lastname: Cundy
authors.affiliation: Medical Oncology, Auckland City Hospital, Auckland, New Zealand.
authors.forename: D
authors.initials: D
authors.lastname: Porter
authors.affiliation: Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
authors.forename: A
authors.initials: A
authors.lastname: Grey
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2; D050171:Dyslipidemias; D046152:Gastrointestinal Stromal Tumors / Q000628:therapy*; D006801:Humans; D000068877:Imatinib Mesylate / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010005:Osteoarthropathy, Secondary Hypertrophic / Q000139:chemically induced* / Q000473:pathology; D014820:Vitiligo
chemical_list: D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate; D000469:Alkaline Phosphatase